Literature DB >> 7892258

Specific T-cell tolerance may reflect selective activation of lymphokine synthesis.

L Vidard1, L J Colarusso, B Benacerraf.   

Abstract

Selective T-cell unresponsiveness, as measured by interleukin 2 (IL-2) synthesis upon challenge with antigen, was induced in SJL mice by ovalbumin (OVA) in incomplete or complete Freund's adjuvant administered i.p. or s.c. Ten days later, the mice were given booster injections of 100 micrograms of OVA/complete Freund's adjuvant. On day 20, lymph node and spleen cells were challenged in vitro with serial dilutions of OVA. There was an antigen-specific dose-dependent down regulation of IL-2 production and T-cell proliferation in lymph node T cells. Concomitantly, 100 micrograms of OVA up regulated IL-4 and, to a lesser extent, interferon gamma (IFN-gamma) production, particularly by spleen T cells. Altogether, these data indicate that the drop of IL-2 production and T-cell proliferation, as well as the up regulation of IL-4 and IFN-gamma production, are complex manifestations of an evolving T-cell response. The maturation of the T-cell response leads to the production of different patterns of lymphokines, which may be significantly affected, as desired, by dosage, timing, and route of immunization, as well as by the choice of adjuvants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7892258      PMCID: PMC42463          DOI: 10.1073/pnas.92.6.2259

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Autoimmune disorders and pregnancy.

Authors:  M W Varner
Journal:  Semin Perinatol       Date:  1991-06       Impact factor: 3.300

Review 2.  Diversity of cytokine synthesis and function of mouse CD4+ T cells.

Authors:  T R Mosmann; J H Schumacher; N F Street; R Budd; A O'Garra; T A Fong; M W Bond; K W Moore; A Sher; D F Fiorentino
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

3.  IL-4 directs the development of Th2-like helper effectors.

Authors:  S L Swain; A D Weinberg; M English; G Huston
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

4.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

5.  CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro.

Authors:  S L Swain; A D Weinberg; M English
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

6.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.

Authors:  P Scott; P Natovitz; R L Coffman; E Pearce; A Sher
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.

Authors:  G Le Gros; S Z Ben-Sasson; R Seder; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

8.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.

Authors:  E J Pearce; P Caspar; J M Grzych; F A Lewis; A Sher
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  6 in total

1.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.

Authors:  Ya Li; Janet S Heuser; Stanley D Kosanke; Mark Hemric; Madeleine W Cunningham
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.

Authors:  L S Harbige; L Layward; M M Morris-Downes; D C Dumonde; S Amor
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 4.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

5.  Inhibition of NF-AT-dependent transcription by NF-kappa B: implications for differential gene expression in T helper cell subsets.

Authors:  V Casolaro; S N Georas; Z Song; I D Zubkoff; S A Abdulkadir; D Thanos; S J Ono
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Boron Induces Lymphocyte Proliferation and Modulates the Priming Effects of Lipopolysaccharide on Macrophages.

Authors:  Indusmita Routray; Shakir Ali
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.